Ranbaxy Laboratories press release(s)
Browse the most recent Ranbaxy Laboratories news/press releases distributed via India PRwire. If you want to subscribe company or industry specific email alerts or RSS feed, please visit our media section. Subscribe to our Breaking News RSS Feed to instantly access 25 most recent press releases across India PRwire network.
Wednesday, 9th May 2007
Pharmaceutical major Ranbaxy Laboratories extends roots in South Africa with finalisation of Be-Tabs acquisitionThe deal is valued at R500 million (USD 70 Million) and will make Ranbaxy the fifth largest generic pharmaceutical company in South Africa. More...
Monday, 30th Apr 2007
Ranbaxy Q1 2007 Net Profit Rises 79% to Rs.129 CroresOperating profit before tax doubles (Rs 1,597 Mn, up 100%); Consolidated Revenues at Rs.15,644 Mn; up 23% compared to corresponding quarter. More...
Wednesday, 25th Apr 2007
Ranbaxy receives us FDA approval to manufacture and market Pravastatin Sodium Tablets in USARanbaxy granted 180 days exclusivity for 80mg dosage More...
Wednesday, 4th Apr 2007
Terapia Ranbaxy receives GMP Certificate renewal from National Agency of Medicine for Bucharest SiteFollowing an inspection conducted by the National Agency of Medicine, the Bucharest based production facility of Terapia Ranbaxy has received a renewal of certification for Good Manufacturing Practice standards at the operational level. More...
Friday, 30th Mar 2007
Ranbaxy annual audited results for year 2006; Net Profit up 95% at Rs.5,154 MN; Global sales at Rs.60,652 MN, + 17% growthBoard approves 2nd interim dividend of 120% taking total dividend for 2006 to 170% More...
Thursday, 29th Mar 2007
Ranbaxy launches Osovair for the treatment of AsthmaWorld's first novel product of its kind introduced in India More...
Wednesday, 21st Mar 2007
Ranbaxy rewards excellence in Medical and Pharmaceutical ResearchRanbaxy Science Foundation, today announced its Annual Research Awards for the year 2005 to the Indian Scientists, in recognition of their outstanding research contributions made by them in the field of Medical and Pharmaceutical Sciences. More...
Monday, 12th Mar 2007
Dr. Himadri Sen to join Ranbaxy as president R&DMove adds muscle to R&D effort and bandwidth to core management team More...
Friday, 2nd Mar 2007
PPD Licenses Statin From Ranbaxy LaboratoriesEarly preclinical studies show potential safety advantage More...
Monday, 26th Feb 2007
Terapia Ranbaxy Receives EU Compliance for Manufacturing and Import AuthorizationIn line with Ranbaxy's plan to transform Terapia Ranbaxy into a strategic regional hub for its operations in Europe, Terapia has received the Manufacturing and Import Authorization according to the European Union (EU) norms and standards. More...
Wednesday, 21st Feb 2007
Ranbaxy Promoters not to sell any part of their equity stakes in Ranbaxy - deny press reportsThe Promoters strongly deny any plan or move on their part to sell any portion of their equity stakes in Ranbaxy to any Private Equity firm or to any others. More...
Tuesday, 13th Feb 2007
Ranbaxy launches Atorvastatin in DenmarkAtorvastatin is a cholesterol-lowering drug which is marketed by Pfizer as Lipitor More...
Wednesday, 7th Feb 2007
Ranbaxy Announces Global Entry into Biosimilars with Zenotech; Targets EU Markets FirstRanbaxy has taken a strategic decision to commit resources to introduce the G-CSF product for global marketing beginning with markets in the EU where regulations for biosimilars are in place. More...
Tuesday, 6th Feb 2007
Ranbaxy signs a New R&D agreement with GlaxoSmithKlineNew multiyear R&D agreement modifies and expands the terms of their strategic alliance established in 2003 to provide Ranbaxy expanded drug-development responsibilities and further financial opportunities. More...
Friday, 2nd Feb 2007
Ranbaxy gains FDA approval to market Amoxicillin and Clavulanate Potassium for Oral Suspension USPAugmentin ES-600 for Oral Suspension has combined sales of $216 million with sales of 600 mg/42.9 mg (base) / 5 mL totaling $136.9 million in the suspension market. More...